新型高弛豫率钆螯合物钆匹克醇在严重肾衰竭大鼠模型中的安全性与钆分布
在腺嘌呤诱导的严重肾衰竭大鼠中,比较钆匹克醇与钆特酸葡胺、钆布醇及线性非离子型钆双胺连续5次静脉注射(每次2.5 mmol/kg,累积12.5 mmol/kg)后的毒性表现与组织钆分布;钆双胺组出现高发病率-死亡率和皮肤病变,钆匹克醇等大环类未见此类效应,组织钆浓度总体较低(肝脏除外)。
要点
- 肾衰竭大鼠中钆双胺出现高发病率-死亡率和宏观/微观皮肤病变,钆匹克醇、钆特酸葡胺、钆布醇未见此类效应。
- 除肝脏(与钆匹克醇无显著差异)及肾、心(各药钆浓度统计学相近)外,钆双胺组各组织元素钆浓度显著高于其他钆对比剂。
- 钆匹克醇与钆特酸葡胺、钆布醇组皮肤结构正常,未见胶原纤维钆沉积及成纤维细胞内含物,与钆双胺不同。
核心结论
- 在肾衰竭大鼠中,钆匹克醇未见生化毒性或皮肤病理异常证据,与其他大环类钆对比剂(钆特酸葡胺、钆布醇)相似,组织钆潴留低(肝脏除外)。
研究设计与样本
- 动物实验:腺嘌呤0.75% wt/wt饮食3周诱导肾衰竭,第2周起每组n=8、共5组,连续5次静脉注射钆对比剂,每次2.5 mmol/kg,累积剂量12.5 mmol/kg,末次注射后3周无治疗期;以电感耦合等离子体质谱测组织元素钆浓度,透射电镜及电子能量损失谱分析皮肤金属沉积,弛豫测量评估皮肤、肝、骨中解离钆,并行皮肤组织病理学检查。
关键影像表现/征象
- 钆双胺组出现宏观和微观皮肤病变,钆匹克醇、钆特酸葡胺、钆布醇组未见此类效应。
- 钆匹克醇、钆特酸葡胺、钆布醇组皮肤结构正常,钆双胺组异常。
- 钆匹克醇及其大环对照未见胶原纤维钆沉积和成纤维细胞内含物,钆双胺组可见。
- 所有试验组真皮巨噬细胞均见钆阳性溶酶体内含物,但质地不同:钆双胺呈斑点状,两种受试大环类钆对比剂呈粗糙质地。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was to investigate the toxicological profile of gadopiclenol, a new high-relaxivity macrocyclic gadolinium-based contrast agent (GBCA), in renally impaired rats, in comparison with 2 other macrocyclic GBCAs, gadoterate meglumine and gadobutrol, and 1 linear and nonionic GBCA, gadodiamide.
METHODS: Renal failure was induced by adding 0.75% wt/wt adenine to the diet for 3 weeks. During the second week of adenine-enriched diet, the animals (n = 8/group × 5 groups) received 5 consecutive intravenous injections of GBCA at 2.5 mmol/kg per injection, resulting in a cumulative dose of 12.5 mmol/kg or saline followed by a 3-week treatment-free period after the last injection. The total (elemental) gadolinium (Gd) concentration in different tissues (brain, cerebellum, femoral epiphysis, liver, skin, heart, kidney, spleen, plasma, urine, and feces) was measured by inductively coupled plasma mass spectrometry. Transmission electron microscopy (and electron energy loss spectroscopy analysis of metallic deposits) was used to investigate the presence and localization of Gd deposits in the skin. Relaxometry was used to evaluate the presence of dissociated Gd in the skin, liver, and bone. Skin histopathology was performed to investigate the presence of nephrogenic systemic fibrosis-like lesions.
RESULTS: Gadodiamide administrations were associated with high morbidity-mortality but also with macroscopic and microscopic skin lesions in renally impaired rats. No such effects were observed with gadopiclenol, gadoterate, or gadobutrol. Overall, elemental Gd concentrations were significantly higher in gadodiamide-treated rats than in rats treated with the other GBCAs for all tissues except the liver (where no significant difference was found with gadopiclenol) and the kidney and the heart (where statistically similar Gd concentrations were observed for all GBCAs). No plasma biochemical abnormalities were observed with gadopiclenol or the control GBCAs. Histopathology revealed a normal skin structure in the rats treated with gadopiclenol, gadoterate, and gadobutrol, contrary to those treated with gadodiamide. No evidence of Gd deposits on collagen fibers and inclusions in fibroblasts was found with gadopiclenol and its macrocyclic controls, unlike with gadodiamide. Animals of all test groups had Gd-positive lysosomal inclusions in the dermal macrophages. However, the textures differed for the different products (speckled texture for gadodiamide and rough-textured appearance for the 2 tested macrocyclic GBCAs).
CONCLUSIONS: No evidence of biochemical toxicity or pathological abnormalities of the skin was observed, and similar to other macrocyclic GBCAs, gadoterate and gadobutrol, tissue retention of Gd was found to be low (except in the liver) in renally impaired rats treated with the new high-relaxivity GBCA gadopiclenol.
引用
- Fretellier N, Rasschaert M, Bocanegra J, et al. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure. Invest Radiol. 2021. PMID: 34091462. doi:10.1097/RLI.0000000000000793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。